Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IZ1D
|
||||
Former ID |
DIB009881
|
||||
Drug Name |
Brofaromine
|
||||
Synonyms |
Brofaremine; Consonar; Consonev; Brofaromine hydrochloride; CGP-11305A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Discontinued in Phase 2 | [544708] | ||
Company |
Novartis AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H16BrNO2
|
||||
Canonical SMILES |
o1c(cc2c1c(cc(c2)OC)Br)C1CCNCC1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] A | Target Info | Modulator | [533333] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.